Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA Approves 1st New Schizophrenia Drug in Decades
US FDA Approves GE HealthCare's Diagnostic Drug for Heart Disease
(Reuters) - The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery disease, the company said on Friday.
FDA Approves the First New Schizophrenia Drug in Decades
No new treatments for schizophrenia have been approved in nearly three decades, but that changed on Sept. 26, when the U.S. Food and Drug Administration (FDA) approved Cobenfy for the psychiatric disorder.
Bristol Myers wins US FDA approval for new type of schizophrenia drug
The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the first new type of antipsychotic medicine in decades.
FDA Approves New Kind of Drug for Schizophrenia
The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and Drug Administration. Cobenfy (xanomeline/trospium chloride) could bring patients what they've long hoped for: A means of easing the hallucinations and "voices" that disrupt their lives without the weight gain and sluggishness of current dopamine-focused drugs.
2d
on MSN
Tech Moves: GE healthcare exec joins startup; Nautilus taps new CMO; WRF investor steps down
Selvan Senthivel is the new chief technology officer for the 6-year-old Seattle startup. Senthivel was most recently CTO for ...
1d
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of ...
3d
GE HealthCare cut to sell by UBS over Chinese competition concerns
GE HealthCare (GEHC) was cut to sell by UBS on Thursday, with the bank asserting that risks such as increasing Chinese ...
2d
UBS Downgrades GE HealthCare Technologies (BVC:GEHC)
Fintel reports that on September 26, 2024, UBS downgraded their outlook for GE HealthCare Technologies ( BVC:GEHC) from ...
1d
GE HealthCare Gets FDA Approval of Flyrcado to Diagnose Coronary Heart Disease
GE HealthCare has received approval for Flyrcado, its enhanced diagnosis tool for coronary heart disease, from the Food and Drug Administration. The company said on Friday that Flyrcado, or ...
3d
GE HealthCare Showcases the Latest AI-enhanced Radiation Therapy Solutions at ASTRO 2024
GE HealthCare (Nasdaq: GEHC) today announced its latest innovations in radiation oncology that will be showcased at the ...
FierceBiotech
11d
GE HealthCare claims FDA clearance for amyloid imaging software in Alzheimer’s disease
GE HealthCare’s recently acquired MIM Software division has secured an FDA clearance for a tool to help quantify the density ...
2d
BTIG upgrades GE Healthcare Technologies Inc (GEHC) to a Buy
In a report released yesterday, Ryan Zimmerman from BTIG upgraded GE Healthcare Technologies Inc (GEHC – Research Report) to a Buy, with ...
Modern Healthcare
2d
Top digital health funding: Nvidia invests in Hippocratic AI
Hippocratic AI is developing a generative AI model that aims to help providers complete non-diagnostic and patient-facing ...
MassDevice
10d
GE HealthCare picks up FDA nod for new brain imaging tool for Alzheimer’s
The GE HealthCare imaging tool is coming out as pharma companies release new therapies onto the market to help treat the ...
3d
on MSN
These Stocks Are Moving the Most Today: Micron, Nvidia, Southwest, Accenture, CarMax, Starbucks, GE Healthcare, and More
Micron stock surges after strong earnings and guidance, fellow chip makers such as Nvidia and ASML rally, Southwest Airlines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Ai
micron stock
Nvidia
Food and Drug Administration
Chief technology officer
Feedback